✦ LIBER ✦

Dermatomyositis with inclusion body myositis pathology

✍ Scribed by Robert Layzer; Han Sung Lee; Donald Iverson; Marta Margeta

Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 304 KB
Volume: 40
Category: Article
ISSN: 0148-639X
DOI: 10.1002/mus.21377

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

The pathogenic role of inflammation in inclusion body myositis (IBM) remains uncertain. A 63‐year‐old man developed a severe, rapidly progressive myopathy with clinical features typical of dermatomyositis (DM), but muscle pathology was typical of IBM. Treatment with prednisone and methotrexate resulted in complete remission of symptoms. Together with two similar cases reported previously, this case suggests that the inflammatory process of DM may trigger the pathologic changes of IBM. Muscle Nerve, 2009

📜 SIMILAR VOLUMES

Inclusion body myositis: Clinical and pa

Inclusion body myositis: Clinical and pathological boundaries

✍ Dr. Anthony A. Amato; Gary S. Gronseth; Carlayne E. Jackson; Gil I. Wolfe; Jon S 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 629 KB

Molecular pathology and pathogenesis of

Molecular pathology and pathogenesis of inclusion-body myositis

✍ Valerie Askanas; W. King Engel 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 315 KB

## Abstract We summarize the molecular phenotype, diagnostic criteria, and the newest advances related to seeking the pathogenic mechanism(s) of sporadic inclusion‐body myositis (s‐IBM), a muscle disease usually of persons over age 50. On the basis of our research, several processes seem to be impo

Inclusion-body myositis and myopathies

✍ Richard J. Barohn 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 1 views

The stated purpose of this volume is to provide a concise and quick reference to the various statistical terms that are used in the scientific literature. It is intended for use by both researchers and students in many academic disciplines. With the present volume, the author has achieved this aim a

Leukocytapheresis in inclusion body myos

Leukocytapheresis in inclusion body myositis

✍ Peter C. Dau 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 285 KB

A patient with inclusion body niyositis was treated with a course of 22 leukocytaphereses combined with prednisone and azathioprine therapy. He improved clinically during an induction phase of frequent cytapheresis, which reduced the circulating levels of T lymphocytes and monocytes and decreased th

Genetics of inclusion-body myositis

✍ M. Needham; F.L. Mastaglia; M.J. Garlepp 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 228 KB

Inclusion body myositis and myopathies

✍ Dr Robert C. Griggs; Valerie Askanas; Salvatore DiMauro; Andrew Engel; George Ka 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 898 KB